{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidgff7kqtwcnat72vnpc2euf6cdh2lad6nvxzfrqdhemt3fet2mey",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3menzoefbb7q2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiccnzdailtjdt4did2wufck7cmbpv3m2ifil4jg3qieqjrtumqqia"
    },
    "mimeType": "image/jpeg",
    "size": 94541
  },
  "path": "/pharmalot/2026/02/11/merck-aids-hiv-access-gilead-pricing/?utm_campaign=rss",
  "publishedAt": "2026-02-11T21:21:53.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "drug pricing",
    "HIV/AIDS",
    "Merck",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.",
  "title": "STAT+: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested",
  "updatedAt": "2026-02-11T21:58:26.000Z"
}